266 related articles for article (PubMed ID: 24154861)
1. Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A.
Dong A; Seidel C; Snell D; Ekawardhani S; Ahlskog JK; Baumann M; Shen J; Iwase T; Tian J; Stevens R; Hackett SF; Stumpp MT; Campochiaro PA
Angiogenesis; 2014 Jul; 17(3):553-62. PubMed ID: 24154861
[TBL] [Abstract][Full Text] [Related]
2. Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor.
Miki K; Miki A; Matsuoka M; Muramatsu D; Hackett SF; Campochiaro PA
Ophthalmology; 2009 Sep; 116(9):1748-54. PubMed ID: 19643496
[TBL] [Abstract][Full Text] [Related]
3. The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.
Zeng M; Shen J; Liu Y; Lu LY; Ding K; Fortmann SD; Khan M; Wang J; Hackett SF; Semenza GL; Campochiaro PA
J Mol Med (Berl); 2017 Apr; 95(4):417-429. PubMed ID: 28004126
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration.
Ding K; Eaton L; Bowley D; Rieser M; Chang Q; Harris MC; Clabbers A; Dong F; Shen J; Hackett SF; Touw DS; Bixby J; Zhong S; Benatuil L; Bose S; Grinnell C; Preston GM; Iyer R; Sadhukhan R; Marchie S; Overmeyer G; Ghayur T; van Riet DA; Tang S; Campochario PA; Gu J
MAbs; 2017; 9(2):269-284. PubMed ID: 27929753
[TBL] [Abstract][Full Text] [Related]
5. Ocular neovascularization.
Campochiaro PA
J Mol Med (Berl); 2013 Mar; 91(3):311-21. PubMed ID: 23329331
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.
Silva RLE; Kanan Y; Mirando AC; Kim J; Shmueli RB; Lorenc VE; Fortmann SD; Sciamanna J; Pandey NB; Green JJ; Popel AS; Campochiaro PA
Sci Transl Med; 2017 Jan; 9(373):. PubMed ID: 28100839
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of retinal and choroidal vascular diseases.
Campochiaro PA
Prog Retin Eye Res; 2015 Nov; 49():67-81. PubMed ID: 26113211
[TBL] [Abstract][Full Text] [Related]
8. Agents that bind annexin A2 suppress ocular neovascularization.
Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
[TBL] [Abstract][Full Text] [Related]
9. Sipjeondaebo-tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Lee YM; Kim CS; Sohn E; Jo K; Lim HR; Kim SK; Kim JS; Kim J
Tohoku J Exp Med; 2014 Nov; 234(3):229-36. PubMed ID: 25365937
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress promotes ocular neovascularization.
Dong A; Xie B; Shen J; Yoshida T; Yokoi K; Hackett SF; Campochiaro PA
J Cell Physiol; 2009 Jun; 219(3):544-52. PubMed ID: 19142872
[TBL] [Abstract][Full Text] [Related]
11. AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration.
Liu Y; Fortmann SD; Shen J; Wielechowski E; Tretiakova A; Yoo S; Kozarsky K; Wang J; Wilson JM; Campochiaro PA
Mol Ther; 2018 Feb; 26(2):542-549. PubMed ID: 29292162
[TBL] [Abstract][Full Text] [Related]
12. HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr⁻/⁻ mice.
Kim J; Kim CS; Jo K; Cho YS; Kim HG; Lee GH; Lee YM; Sohn E; Kim JS
Biochem Biophys Res Commun; 2015 Jan; 456(1):53-8. PubMed ID: 25446077
[TBL] [Abstract][Full Text] [Related]
13. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.
Vinores SA; Xiao WH; Aslam S; Shen J; Oshima Y; Nambu H; Liu H; Carmeliet P; Campochiaro PA
J Cell Physiol; 2006 Mar; 206(3):749-58. PubMed ID: 16245301
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
16. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
Ozaki H; Seo MS; Ozaki K; Yamada H; Yamada E; Okamoto N; Hofmann F; Wood JM; Campochiaro PA
Am J Pathol; 2000 Feb; 156(2):697-707. PubMed ID: 10666398
[TBL] [Abstract][Full Text] [Related]
17. A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.
Zhang L; Shen X; Lu Q; Zhou Q; Gu J; Gan R; Zhang H; Sun X; Xie B
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):731-9. PubMed ID: 21881847
[TBL] [Abstract][Full Text] [Related]
18. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice.
Vinores SA; Derevjanik NL; Vinores MA; Okamoto N; Campochiaro PA
Adv Exp Med Biol; 2000; 476():129-38. PubMed ID: 10949661
[TBL] [Abstract][Full Text] [Related]
20. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.
Ohno-Matsui K; Hirose A; Yamamoto S; Saikia J; Okamoto N; Gehlbach P; Duh EJ; Hackett S; Chang M; Bok D; Zack DJ; Campochiaro PA
Am J Pathol; 2002 Feb; 160(2):711-9. PubMed ID: 11839592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
